formats

How a premature ejaculation drug sparked a $150 million legal battle over trade secrets

The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade secrets.

All rights reserved to: UIG | United Investment Group 2012 , Powered By: UCG.ae